Promising results from Viaskin patch research.
Tag: oit
OIT Therapy Gets Ready for Prime Time
Peanut oral immunotherapy in a capsule is moving closer to regulatory approval in the United States. The therapy brings hope – not for a cure – but of lives made less vulnerable.
FARE’s Dr. Baker: Finding Peace of Mind While We Search for a Cure
Why FARE (Food Allergy Research & Education) thinks desensitization is a vital food allergy therapy on the path toward finding tolerance.
Standarized OIT Takes Steps Forward
A pharmaceutical approach to oral immunotherapy is a step closer to approval by the Food and Drug Administration. The treatment,… Read more »
Walnut OIT Shows Promise in Small Study
While oral immunotherapy for peanut allergy grabs plenty of headlines, the question is often raised whether the technique will work… Read more »
OIT’s Effects Endure at Low Doses: Stanford Study
In a long-term follow-up study, oral immunotherapy (OIT) patients who were treated for up to five food allergies were able to maintain a high level of desensitization to their allergens, even those taking very low “doses” of their allergens.
Brave Pioneers: The Families in Food Allergy Trials
They’re the courageous food allergy parents and children testing therapies still in the experimental stages.
Drug Xolair Significantly Cuts Down Reactions in Milk Allergy OIT
Patients taking the drug had one-third the number of reactions of a placebo group while doing OIT
The MD Training Baby’s Immune System Not to Be Allergic
Dr. Brian Vickery was interested in cardiology before he spent time as a pediatric resident in New York City. There,… Read more »
OIT More Successful in Babies, New Study Finds
Testing OIT in such a young population has never been done before, but results show that it’s worth it.